Protein Targets

The term "Protein Targets" refers to a broad and non-specific category of biological molecules, primarily proteins, that are the focus of drug discovery and therapeutic intervention. This is not a specific molecular entity but rather a collective term for various classes of proteins, such as receptors, enzymes, and transporters, which can be modulated by drugs to treat diseases (Santos et al., 2017, Nature Reviews Drug Discovery). Because it encompasses thousands of distinct proteins with diverse physiological roles, it cannot be characterized by a single set of biological functions or disease associations (Overington et al., 2006, Nature Reviews Drug Discovery). In a clinical or pharmacological context, specific protein targets must be identified to determine the mechanism of action, safety profiles, and therapeutic efficacy (NIH/NCATS). These targets are the foundation of modern pharmacology, as most approved drugs exert their effects by binding to specific protein structures to alter biochemical pathways. However, the term itself is too broad for clinical or research specificity, as each target requires unique validation and safety assessment. Consequently, "Protein Targets" is considered an incorrect or overly broad designation for a specific therapeutic target.

Other names

Drug targetsTherapeutic targetsBiological targetsMolecular targets

The mechanism of action varies significantly across the diverse range of proteins included in this category, encompassing agonism, antagonism, and enzymatic inhibition.